Michael S Weinstock1, Amber D Shaffer2, Amanda L Stapleton1. 1. Department of Otolaryngology, Division of Pediatric Otolaryngology, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, PA, United States of America. 2. Department of Otolaryngology, Division of Pediatric Otolaryngology, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, PA, United States of America. Electronic address: shafferad@upmc.edu.
Abstract
PURPOSE: Pediatric cystic fibrosis (CF) patients have a variable onset, severity, and progression of sinonasal disease. The objective of this study was to identify genotypic and phenotypic factors associated with CF that are predictive of sinonasal disease, recurrent nasal polyposis, and failure to respond to standard treatment. METHODS: A retrospective case series was conducted of 30 pediatric patients with CF chronic rhinosinusitis with and without polyps. Patient specific mutations were divided by class and categorized into high risk (Class I-III) and low risk (Class IV-V). Severity of pulmonary and pancreatic manifestations of CF, number of sinus surgeries, nasal polyposis and recurrence, age at presentation to Otolaryngology, and Pediatric Sinonasal Symptom Survey (SN-5)/Sinonasal Outcome Test (SNOT-22) scores were examined. RESULTS: 27/30 patients (90%) had high risk mutations (Class I-III). 21/30 (70.0%) patients had nasal polyposis and 10/30 (33.3%) had recurrent nasal polyposis. Dependence on pancreatic enzymes (23/27, 85.2% vs 0/3, 0.0%, p = 0.009) and worse forced expiratory volumes (FEV1%) (mean 79, SD 15 vs mean 105, SD 12, p = 0.009) were more common in patients with high risk mutations. Insulin-dependence was more common in those with recurrent polyposis (5/10, 50% vs 2/20, 10%, p = 0.026). There was no statistical difference in ages at presentation, first polyps, or sinus surgery, or in polyposis presence, recurrence, or extent of sinus surgery based on high risk vs. low risk classification. CONCLUSION: CF-related diabetes was associated with nasal polyposis recurrence. Patients with more severe extra-pulmonary manifestations of CF may also be at increased risk of sinonasal disease.
PURPOSE: Pediatric cystic fibrosis (CF) patients have a variable onset, severity, and progression of sinonasal disease. The objective of this study was to identify genotypic and phenotypic factors associated with CF that are predictive of sinonasal disease, recurrent nasal polyposis, and failure to respond to standard treatment. METHODS: A retrospective case series was conducted of 30 pediatric patients with CF chronic rhinosinusitis with and without polyps. Patient specific mutations were divided by class and categorized into high risk (Class I-III) and low risk (Class IV-V). Severity of pulmonary and pancreatic manifestations of CF, number of sinus surgeries, nasal polyposis and recurrence, age at presentation to Otolaryngology, and Pediatric Sinonasal Symptom Survey (SN-5)/Sinonasal Outcome Test (SNOT-22) scores were examined. RESULTS: 27/30 patients (90%) had high risk mutations (Class I-III). 21/30 (70.0%) patients had nasal polyposis and 10/30 (33.3%) had recurrent nasal polyposis. Dependence on pancreatic enzymes (23/27, 85.2% vs 0/3, 0.0%, p = 0.009) and worse forced expiratory volumes (FEV1%) (mean 79, SD 15 vs mean 105, SD 12, p = 0.009) were more common in patients with high risk mutations. Insulin-dependence was more common in those with recurrent polyposis (5/10, 50% vs 2/20, 10%, p = 0.026). There was no statistical difference in ages at presentation, first polyps, or sinus surgery, or in polyposis presence, recurrence, or extent of sinus surgery based on high risk vs. low risk classification. CONCLUSION: CF-related diabetes was associated with nasal polyposis recurrence. Patients with more severe extra-pulmonary manifestations of CF may also be at increased risk of sinonasal disease.
Authors: Bao Anh Julie Do; Larry C Lands; Christine Saint-Martin; Marco A Mascarella; John J Manoukian; Sam J Daniel; Lily H P Nguyen Journal: Int J Pediatr Otorhinolaryngol Date: 2014-04-26 Impact factor: 1.675
Authors: Sarfaraz M Banglawala; Rodney J Schlosser; Kristen Morella; Rakesh Chandra; Justin Khetani; David M Poetker; Meera Rayar; Luke Rudmik; Nathan B Sautter; Doron D Sommer; Timothy L Smith; Zachary M Soler Journal: Int Forum Allergy Rhinol Date: 2015-12-18 Impact factor: 3.858
Authors: Eulalia Sakano; Antonio F Ribeiro; Leo Barth; Antonio Condino Neto; José D Ribeiro Journal: Int J Pediatr Otorhinolaryngol Date: 2006-09-27 Impact factor: 1.675
Authors: Zachary Farhood; Rodney J Schlosser; Madeline E Pearse; Kristina A Storck; Shaun A Nguyen; Zachary M Soler Journal: Int Forum Allergy Rhinol Date: 2015-11-26 Impact factor: 3.858
Authors: Waleed M Abuzeid; Changeun Song; Judd H Fastenberg; Christina H Fang; Noel Ayoub; Elina Jerschow; Paul K Mohabir; Peter H Hwang Journal: Laryngoscope Date: 2017-11-29 Impact factor: 3.325
Authors: Geoffrey R Ferril; Jerry A Nick; Anne E Getz; Henry P Barham; Milene T Saavedra; Jennifer L Taylor-Cousar; David P Nichols; Douglas Curran-Everett; Todd T Kingdom; Vijay R Ramakrishnan Journal: Int Forum Allergy Rhinol Date: 2014-09-15 Impact factor: 3.858